Elizabeth Miller
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elizabeth Miller has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Nick Andrews
UK Health Security Agency
2 shared publications Albert Jan van Hoek
Immunisation Hepatitis and Blood Safety Department, Public Health England, London, United Kingdom
1 shared publication- Bassam Hallis
Immunoassay Laboratory, National Infection Service, Public Health England, Porton Down SP4 0JG, United Kingdom
1 shared publication - Carmen L. Sheppard
Present address: Genpax Ltd, 9 Pembridge Road, Notting Hill, London, W11 3JY, UK
1 shared publication - David Litt
Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK
1 shared publication - Donna Haskins
PHE Immunisation and Countermeasures Division, Public Health England, 61 Colindale Avenue, NW9 5EQ London, United Kingdom
1 shared publication
Latest Publications
- 1 October 2021
- Published by Elsevier in Journal of Infection
- Vol. 83 (4) , 483-489
Transmission of SARS-CoV-2 in the household setting: A prospective cohort study in children and adults in England
- 1 October 2021
- Published by Elsevier in Journal of Infection
- Vol. 83 (4) , 483-489
Transmission of SARS-CoV-2 in the household setting: A prospective cohort study in children and adults in England
- Open Access
The Genomics of Streptococcus pneumoniae Carriage Isolates from UK Children and Their Household Contacts, Pre-PCV7 to Post-PCV13
We used whole genome sequencing (WGS) analysis to investigate the population structure of 877 Streptococcus pneumoniae isolates from five carriage studies from 2002 (N = 346), 2010 (N = 127), 2013 (N = 153), 2016 (N = 187) and 2018 (N = 64) in UK households which covers the period pre-PCV7 to post-PCV13 implementation. The genomic lineages seen in the population were determined using multi-locus sequence typing (MLST) and PopPUNK (Population Partitioning Using Nucleotide K-mers) which was used for local and global comparisons. A Roary core genome alignment of all the carriage genomes was used to investigate phylogenetic relationships between the lineages. The results showed an influx of previously undetected sequence types after vaccination associated with non-vaccine serotypes. A small number of lineages persisted throughout, associated with both non-vaccine and vaccine types (such as ST199), or that could be an example of serotype switching from vaccine to non-vaccine types (ST177). Serotype 3 persisted throughout the study years, represented by ST180 and Global Pneumococcal Sequencing Cluster (GPSC) 12; the local PopPUNK analysis and core genome maximum likelihood phylogeny separated them into two clades, one of which is only seen in later study years. The genomic data showed that serotype replacement in the carriage studies was mostly due to a change in genotype as well as serotype, but that some important genetic lineages, previously associated with vaccine types, persisted.
Open AccessThe Genomics of Streptococcus pneumoniae Carriage Isolates from UK Children and Their Household Contacts, Pre-PCV7 to Post-PCV13
We used whole genome sequencing (WGS) analysis to investigate the population structure of 877 Streptococcus pneumoniae isolates from five carriage studies from 2002 (N = 346), 2010 (N = 127), 2013 (N = 153), 2016 (N = 187) and 2018 (N = 64) in UK households which covers the period pre-PCV7 to post-PCV13 implementation. The genomic lineages seen in the population were determined using multi-locus sequence typing (MLST) and PopPUNK (Population Partitioning Using Nucleotide K-mers) which was used for local and global comparisons. A Roary core genome alignment of all the carriage genomes was used to investigate phylogenetic relationships between the lineages. The results showed an influx of previously undetected sequence types after vaccination associated with non-vaccine serotypes. A small number of lineages persisted throughout, associated with both non-vaccine and vaccine types (such as ST199), or that could be an example of serotype switching from vaccine to non-vaccine types (ST177). Serotype 3 persisted throughout the study years, represented by ST180 and Global Pneumococcal Sequencing Cluster (GPSC) 12; the local PopPUNK analysis and core genome maximum likelihood phylogeny separated them into two clades, one of which is only seen in later study years. The genomic data showed that serotype replacement in the carriage studies was mostly due to a change in genotype as well as serotype, but that some important genetic lineages, previously associated with vaccine types, persisted.
- Open Access
- 4 October 2016
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 13 (10) , e1002141
Sailing in Uncharted Waters: Carefully Navigating the Polio Endgame
In a Perspective linked to the research article by Isobel Blake and colleagues, Elizabeth Miller and T. Jacob John discuss the path towards global polio eradication and the challenges, strategies, and necessary precautions around oral polio vaccine cessation.
- 4 October 2016
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 13 (10) , e1002141
Open AccessSailing in Uncharted Waters: Carefully Navigating the Polio Endgame
In a Perspective linked to the research article by Isobel Blake and colleagues, Elizabeth Miller and T. Jacob John discuss the path towards global polio eradication and the challenges, strategies, and necessary precautions around oral polio vaccine cessation.
- Open Access
- 16 October 2015
- Published by Springer Nature in BMC Medicine
- Vol. 13 (1) , 1-5
Controversies and challenges of vaccination: an interview with Elizabeth Miller
Although strong evidence exists that the benefits of vaccination by far outweigh potential adverse events, controversy still exists. This has led opponents of vaccination to question its safety, efficacy and necessity. In an interview with Professor Elizabeth Miller, we discuss the continuum of beliefs held by vaccine refusers and hesitators, the resulting health consequences, and ways in which health professionals and industry regulators can help promote transparency to better convey the substantial health benefits of vaccination.
- 16 October 2015
- Published by Springer Nature in BMC Medicine
- Vol. 13 (1) , 1-5
Open AccessControversies and challenges of vaccination: an interview with Elizabeth Miller
Although strong evidence exists that the benefits of vaccination by far outweigh potential adverse events, controversy still exists. This has led opponents of vaccination to question its safety, efficacy and necessity. In an interview with Professor Elizabeth Miller, we discuss the continuum of beliefs held by vaccine refusers and hesitators, the resulting health consequences, and ways in which health professionals and industry regulators can help promote transparency to better convey the substantial health benefits of vaccination.
- Open Access
- 3 November 2013
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 58 (2) , 195-6
Editorial commentary: seasonal changes in pneumococcal disease--still much of an enigma.
- 3 November 2013
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 58 (2) , 195-6
Open AccessEditorial commentary: seasonal changes in pneumococcal disease--still much of an enigma.